Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

Ministry of Food and Drug Safety 국민 안심이 기준입니다 YOUR SAFETY IS OUR STANDARD

home > Our Works > Bio&Cosmetics > Manufactures
Manufactures|Bio&Cosmetics|Our Works|Ministry of Food and Drug Safety

Biological Products

(Recombinant DNA products) CJ HealthCare Corp.
  • Registration Date 2016-07-11
  • Hit 3438

Company Information

1. Name

CJ HealthCare corp

2. Website Address

http://www.cjp.co.kr/

3. Location

CJ CheilJedang Center, 330, Dongho-ro, Jung-gu, Seoul 100-400, Korea

4. Contacts

TEL: +82-2-6740-2169

E-MAIL: CJHC_business@cj.net

5. References

-

Pharmaceutical Product Information

1. Barnd Name

Epokine

2. Active Ingredient

Recombinant human erythropoietin
1000, 2000, 3000, 4000, 10000 Units per prefilled-syringe or vial

3. Indication

ⓐ Treatment of anemia in chronic renal failure patients

ⓑ Treatment of anemia in cancer patients on chemotherapy

ⓒ For the patients participating in self blood preservation

4. Information

 Epokine® is the most reliable choice for renal anemia and was developed 1st in Korea and 3rd in the world.
Epokine® is safe and effective in treating anemia of hemodialysis patients with end-stage renal disease.

5. Images

Pharmaceutical Product Information

1. Barnd Name

Leukokine®

2. Active Ingredient

Filgrastim (Recombinant human methionyl granulocyte colony-stimulating factor: r-metHuG-CSF)
150㎍/0.6mL, 300㎍/1.2mL

3. Indication

ⓐ Acceleration of an increase in the number of neutrophils following bone marrow transplantation
ⓑ Neutropenia caused by cancer chemotherapy: malignant lymphoma, lung cancer, ovarian cancer, testicular cancer, neuroblastoma and acute leukemia

4. Information

Leukokine® has the same efficacy and safety with those of the control on neutropenia
- For the neutropenia induced by chemotherapy in advanced cancer patients
- For the neutropenia induced by chemotherapy in acute leukemia patients

5. Images

Attached File

Division

Written by 전형옥

List